He, H., Yan, M., Ye, K., Shi, R., Tong, L., Zhang, S., . . . Zhan, R. (2025). Predicting Prognosis and Immunotherapy Response in Glioblastoma (GBM) With a 5‐Gene CAF‐Risk Signature. Cancer Reports, 8(4), . https://doi.org/10.1002/cnr2.70158
Chicago-referens (17:e uppl.)He, Haifeng, Min Yan, Ke Ye, Rui Shi, Luqing Tong, Shengxiang Zhang, Yu Zhu, och Renya Zhan. "Predicting Prognosis and Immunotherapy Response in Glioblastoma (GBM) With a 5‐Gene CAF‐Risk Signature." Cancer Reports 8, no. 4 (2025). https://doi.org/10.1002/cnr2.70158.
MLA-referens (9:e uppl.)He, Haifeng, et al. "Predicting Prognosis and Immunotherapy Response in Glioblastoma (GBM) With a 5‐Gene CAF‐Risk Signature." Cancer Reports, vol. 8, no. 4, 2025, https://doi.org/10.1002/cnr2.70158.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
